Targeting Intramembrane Protein-Protein Interactions: Novel Therapeutic Strategy of Millions Years Old.
Targeting Intramembrane Protein-Protein Interactions: Novel Therapeutic Strategy of Millions Years Old.
复制标题
DOI：
10.1016/bs.apcsb.2017.06.004
复制
发表时间：
2018
影响因子：
--
通讯作者：
Sigalov AB
中科院分区：
文献类型：
--
作者：
Sigalov AB
Intramembrane protein–protein interactions (PPIs) are involved in transmembrane signal transduction mediated by cell surface receptors and play an important role in health and disease. Recently, receptor-specific modulatory peptides rationally designed using a general platform of transmembrane signaling, the signaling chain homooligomerization (SCHOOL) model, have been proposed to therapeutically target these interactions in a variety of serious diseases with unmet needs including cancer, sepsis, arthritis, retinopathy, and thrombosis. These peptide drug candidates use ligand-independent mechanisms of action (SCHOOL mechanisms) and demonstrate potent efficacy in vitro and in vivo. Recent studies surprisingly revealed that in order to modify and/or escape the host immune response, human viruses use similar mechanisms and modulate cell surface receptors by targeting intramembrane PPIs in a ligand-independent manner. Here, I review these intriguing mechanistic similarities and discuss how the viral strategies optimized over a billion years of the coevolution of viruses and their hosts can help to revolutionize drug discovery science and develop new, disruptive therapies. Examples are given.
登录
查看更多内容
影响因子：
4.7
作者：
Ali, M;Amon, M;Manolios, N
通讯作者：
Manolios, N
影响因子：
3.3
作者：
Bell, CA;Tynan, JA;Donoghue, DJ
通讯作者：
Donoghue, DJ
影响因子：
2.8
作者：
Angiolillo, Dominick J.;Bhatt, Deepak L.;Jennings, Lisa K.
通讯作者：
Jennings, Lisa K.
影响因子：
64.8
作者：
Bouchon, A;Facchetti, F;Colonna, M
通讯作者：
Colonna, M
DOI：
10.1007/s10989-006-9025-4
发表时间：
2006-09-01
影响因子：
2.5
作者：
Ali, Marina;Salam, Noeris K.;Manolios, Nicholas
通讯作者：
Manolios, Nicholas